Profil
Christian Brechot is the founder of ScreenCell SA, which was founded in 2001.
He is currently the Vice Chairman at Global Virus Network, Director at Fondation Mérieux, Director at Institut Pasteur Korea Research Foundation, Director at Fondation Ophtalmologique Adolphe de Rothschild, Director at European Personalised Medicine Association, and Director at Rarecells Diagnostics SAS. Dr. Brechot's former positions include being a Director at Transgene SA, Director at Biotheranostics, Inc., Director at bioMérieux SA from 2008 to 2012, General Director at Institut National de la Santé & de la Recherche Médicale from 2001 to 2007, Director at Drugs for Neglected Diseases initiative, President at Institut Pasteur from 2013 to 2017, Vice President-Medical & Scientific Affairs at Compagnie Merieux Alliance SAS, and Head-Clinical Department at Hopital Necker-Enfants Malades.
He obtained a doctorate degree from Université Paris 1 Panthéon-Sorbonne in 1985.
Aktive Positionen von Christian Brechot
| Unternehmen | Position | Beginn |
|---|---|---|
Fondation Mérieux
Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | - |
Fondation Ophtalmologique Adolphe de Rothschild
Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Operates a hospital for the treatment and diagnosis of opthalmic and neurologic diseases | Direktor/Vorstandsmitglied | - |
European Personalised Medicine Association | Direktor/Vorstandsmitglied | - |
Institut Pasteur Korea
Institut Pasteur Korea BiotechnologyHealth Technology Provides research and development for the treatment of infectious and chronic diseases | Direktor/Vorstandsmitglied | - |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Direktor/Vorstandsmitglied | - |
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Develops and commercializes ISET technology to isolate circulating cancer cells for early cancer diagnosis & medical research | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christian Brechot
| Unternehmen | Position | Ende |
|---|---|---|
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Präsident | 13.10.2017 |
| BIOMÉRIEUX | Direktor/Vorstandsmitglied | 01.01.2012 |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Corporate Officer/Principal | 01.01.2007 |
| ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Christian Brechot
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
bioMérieux SA
bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Université Paris 1 Panthéon-Sorbonne
Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Commercial Services |
ScreenCell SA
ScreenCell SA Miscellaneous Commercial ServicesCommercial Services Offers clinically confirmed solutions for the isolation of rare cells in the blood and other fluids | Commercial Services |
Fondation Mérieux
Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Compagnie Merieux Alliance SAS
Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Functions as an investment fund | Miscellaneous |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Provides drug and research development services | Health Technology |
Institut Pasteur Korea
Institut Pasteur Korea BiotechnologyHealth Technology Provides research and development for the treatment of infectious and chronic diseases | Health Technology |
Hopital Necker-Enfants Malades | |
Fondation Ophtalmologique Adolphe de Rothschild
Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Operates a hospital for the treatment and diagnosis of opthalmic and neurologic diseases | Health Services |
European Personalised Medicine Association | |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Develops and commercializes ISET technology to isolate circulating cancer cells for early cancer diagnosis & medical research | Technology Services |
















